Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to HER2-negative Breast Cancer
Related studies linked through entity extraction aliases.
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
- Status
- COMPLETED
- Phase
- PHASE2